Literature DB >> 30387003

A systematic review of interventions to improve adherence to endocrine therapy.

Sue P Heiney1, Pearman D Parker2, Tisha M Felder3, Swann Arp Adams3, Omonefe O Omofuma4, Jennifer M Hulett2.   

Abstract

PURPOSE: Adherence to endocrine therapy for hormone positive breast cancer is a significant problem, especially in minority populations. Further, endocrine therapy reduces recurrence and thus mortality. However, little data are available on interventions to improve adherence. The authors conducted a systematic review to examine the impact of interventions, strategies, or approaches aimed to improve endocrine therapy adherence among women with breast cancer. A secondary aim was to determine if interventions had any cultural modifications.
METHODS: Two of the authors examined articles published between 2006 and 2017 from a wide variety of databases using Covidence systematic review platform.
RESULTS: In total, 16 eligible studies met criteria for review including 4 randomized controlled trials, 4 retrospective studies, and 8 with various observational designs. Eligible studies used a broad range of definitions for adherence and measured adherence by self-report, medical records, claims data, and combinations of these. All used 80% medication possession ratio as a standard for adherence. Patient information/education was the most frequent intervention strategy but did not demonstrate a significant effect except in one study. Significant results were noted when education was combined with communication strategies.
CONCLUSIONS: Researchers need a standard definition for adherence and a reliable measure that is feasible to use in a variety of studies. While education may be a necessary component of an intervention, when used alone, it is not a sufficient approach to change behavior.

Entities:  

Keywords:  Adherence; Breast cancer; Endocrine therapy; Interventions; Systematic review

Mesh:

Substances:

Year:  2018        PMID: 30387003      PMCID: PMC7093203          DOI: 10.1007/s10549-018-5012-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  70 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

2.  Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years.

Authors:  Anne Marie McCarthy; Jianing Yang; Katrina Armstrong
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

3.  Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.

Authors:  Gretchen Kimmick; Sara N Edmond; Hayden B Bosworth; Jeffrey Peppercorn; Paul K Marcom; Kimberly Blackwell; Francis J Keefe; Rebecca A Shelby
Journal:  Breast       Date:  2015-07-16       Impact factor: 4.380

4.  The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.

Authors:  Patrick Neven; Christos Markopoulos; Minna Tanner; Michel Marty; Rolf Kreienberg; Louise Atkins; Ann Franquet; Michael Gnant; Silvia Neciosup; Petra Tesarova; Sandro Barni; Veronique Deschamp
Journal:  Breast       Date:  2014-03-24       Impact factor: 4.380

5.  Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

Authors:  Ann H Partridge; Philip S Wang; Eric P Winer; Jerry Avorn
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

Review 6.  Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.

Authors:  Carling J Ursem; Hayden B Bosworth; Rebecca A Shelby; Wenke Hwang; Roger T Anderson; Gretchen G Kimmick
Journal:  J Womens Health (Larchmt)       Date:  2015-04-17       Impact factor: 2.681

7.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

8.  The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer.

Authors:  P Hadji; M Blettner; N Harbeck; C Jackisch; H-J Lück; C Windemuth-Kieselbach; S Zaun; R Kreienberg
Journal:  Ann Oncol       Date:  2013-02-01       Impact factor: 32.976

9.  Making Visible a Theory-Guided Advance Care Planning Intervention.

Authors:  Mi-Kyung Song; Sandra E Ward
Journal:  J Nurs Scholarsh       Date:  2015-07-28       Impact factor: 3.176

10.  Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.

Authors:  Jacqueline G Hugtenburg; Lonneke Timmers; Petra Jm Elders; Marcia Vervloet; Liset van Dijk
Journal:  Patient Prefer Adherence       Date:  2013-07-10       Impact factor: 2.711

View more
  8 in total

1.  Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study.

Authors:  Shruti Bhandari; Phuong Ngo; Blakely Kute; Mounika Mandadi; Whitney A Pitman; Xiaoyong Wu; Sandy Lloyd; Marie Corliss Brown; Shesh N Rai; Dharamvir Jain; Elizabeth C Riley
Journal:  Breast Cancer Res Treat       Date:  2019-06-06       Impact factor: 4.872

Review 2.  Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews.

Authors:  Thu Ha Dang; Abdur Rahim Mohammad Forkan; Nilmini Wickramasinghe; Prem Prakash Jayaraman; Marliese Alexander; Kate Burbury; Penelope Schofield
Journal:  JMIR Cancer       Date:  2022-04-27

3.  Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.

Authors:  Joanna J Arch; Catherine M Crespi; Michael E Levin; Sarah R Genung; Madeline Nealis; Jill L Mitchell; Emma E Bright; Karen Albright; Jessica F Magidson; Annette L Stanton
Journal:  Ann Behav Med       Date:  2022-08-02

4.  Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial.

Authors:  Samuel G Smith; Rachel Ellison; Louise Hall; Jane Clark; Suzanne Hartley; Ellen Mason; Jamie Metherell; Catherine Olivier; Vicky Napp; Jay Naik; Sarah Buckley; Charlotte Hirst; Sue Hartup; Richard D Neal; Galina Velikova; Amanda Farrin; Michelle Collinson; Christopher D Graham
Journal:  Pilot Feasibility Stud       Date:  2022-02-08

5.  Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.

Authors:  Sophie M C Green; David P French; Christopher D Graham; Louise H Hall; Nikki Rousseau; Robbie Foy; Jane Clark; Catherine Parbutt; Erin Raine; Benjamin Gardner; Galina Velikova; Sally J L Moore; Jacqueline Buxton; Samuel G Smith
Journal:  BMC Health Serv Res       Date:  2022-08-24       Impact factor: 2.908

6.  Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study.

Authors:  Susanne Ahlstedt Karlsson; Ingela Henoch; Roger Olofsson Bagge; Catarina Wallengren
Journal:  BMJ Open       Date:  2022-10-05       Impact factor: 3.006

7.  Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

Authors:  Betina Yanez; Robert J Gray; Joseph A Sparano; Ruth C Carlos; Gelareh Sadigh; Sofia F Garcia; Ilana F Gareen; Timothy J Whelan; George W Sledge; David Cella; Lynne I Wagner
Journal:  JAMA Oncol       Date:  2021-06-17       Impact factor: 33.006

8.  Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.

Authors:  Jamie M Jacobs; Emily A Walsh; Chelsea S Rapoport; Michael H Antoni; Elyse R Park; Kathryn Post; Amy Comander; Jeffrey Peppercorn; Steven A Safren; Jennifer S Temel; Joseph A Greer
Journal:  J Clin Psychol Med Settings       Date:  2020-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.